Hap Trading, LLC Eagle Pharmaceuticals, Inc. Transaction History
Hap Trading, LLC
- $1.15 Trillion
- Q4 2024
A detailed history of Hap Trading, LLC transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, Hap Trading, LLC holds 33,600 shares of EGRX stock, worth $39,648. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,600Holding current value
$39,648% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding EGRX
# of Institutions
46Shares Held
4.75MCall Options Held
1MPut Options Held
100-
Nantahala Capital Management, LLC New Canaan, CT2.36MShares$2.78 Million0.52% of portfolio
-
Aqr Capital Management LLC Greenwich, CT375KShares$442,4900.0% of portfolio
-
Black Rock Inc. New York, NY353KShares$416,2590.0% of portfolio
-
Morgan Stanley New York, NY192KShares$226,8110.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny185KShares$218,3680.0% of portfolio
About EAGLE PHARMACEUTICALS, INC.
- Ticker EGRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 13,015,900
- Market Cap $15.4M
- Description
- Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...